MAP4K
-
MAP4K Related Products (57)
Related Products (57)
-
HPK1-IN-14
0 ImagesCat. No.: HY-145040CAS No.: 2734168-45-5HPK1-IN-14 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-14 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 79) .
-
HPK1-IN-11
0 ImagesCat. No.: HY-145037CAS No.: 2734167-68-9HPK1-IN-11 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-11 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 2).
-
HPK1-IN-10
0 ImagesCat. No.: HY-145036CAS No.: 2734168-69-3HPK1-IN-10 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-10 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 103) .
-
HPK1-IN-31
0 ImagesCat. No.: HY-152257CAS No.: 3003026-16-9HPK1-IN-31 (compound 5i) is an orally active hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC50 value of 0.8 nM. HPK1-IN-31 has anti-tumour activity and has great potential for immunoresearch.
-
NG25 trihydrochloride
0 ImagesCat. No.: HY-15434ACAS No.: 2108554-00-1NG25 trihydrochloride is a dual TAK1 and MAP4K2 inhibitor (IC50: 149 nM and 21.7 nM respectively). NG25 sensitizes the breast cancer cells to Doxorubicin (HY-15142A), and enhances apoptosis. NG25 trihydrochloride can be used for research of various cancers.
-
HPK1-IN-57
0 ImagesCat. No.: HY-172594HPK1-IN-57 (Compound 10c) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC50 value of 0.09 nM. HPK1-IN-57 inhibits the activity of HPK1 kinase, hindering the phosphorylation of the downstream adaptor protein SLP76 (IC50 is 33.74 nM) and effectively stimulating the secretion of the T cell activation marker IL-2 (EC50 is 84.24 nM). HPK1-IN-57 is promising for research of tumor immunotherapy.
-
HPK1 antagonist-1
0 ImagesCat. No.: HY-153553CAS No.: 2628489-56-3HPK1 antagonist-1 (I-792) is an Hpk1 antagonist that can be used in the study of cancer and immune disease.
-
HPK1 ligand-Linker Conjugate 1
0 ImagesCat. No.: HY-175551CAS No.: 3061690-80-7
-
HPK1-IN-39
0 ImagesCat. No.: HY-149520HPK1-IN-39 (Compound 10n) is a selective HPK1 Inhibitor (IC50: 29 nM). HPK1-IN-39 inhibits the phosphorylation of SLP76. HPK1-IN-39 can be used for research of cancer immunotherapy.
-
HMC-B17
0 ImagesCat. No.: HY-157838CAS No.: 2935913-83-8
-
HPK1-IN-58
0 ImagesCat. No.: HY-172875CAS No.: 3093724-62-7HPK1-IN-58 (Compound 26) is an inhibitor of HPK1 (IC50: 2.6 nM) and SLP76 (IC50: 20 nM). HPK1-IN-58 enhances IL-2 secretion and reverses PGE2-induced immunosuppression. HPK1-IN-58 can be used in anti-tumor immunity research.
-
HPK1-IN-61
0 ImagesCat. No.: HY-177272CAS No.: 875638-86-1
-
HPK1-IN-41
0 ImagesCat. No.: HY-160217CAS No.: 2828455-23-6HPK1-IN-41 (compound Z389) is a HPK1 inhibitor with an IC50 value of 0.21 μM. HPK1-IN-41 can be used for the research of preventing and/or treating diseases or conditions associated with HPK1 activity.
-
3,4-Dephostatin
0 ImagesCat. No.: HY-124152CAS No.: 173043-84-0Synonyms: Methyl-3,4-dephostatin3,4-Dephostatin (Methyl-3,4-dephostatin) is an inhibitor of protein-tyrosine phosphatase (PTPase). 3,4-Dephostatin accelerates nerve growth factor (NGF)-induced neurite formation in PC12h cells. 3,4-Dephostatin sustains the NGF-induced tyrosine phosphorylation of proteins, most prominently that of mitogen-activated protein (MAP) kinase. 3,4-Dephostatin also prolongs epidermal growth factor (EGF)-induced tyrosine phosphorylation and activation of MAP kinase.
-
HPK1-IN-27
0 ImagesCat. No.: HY-143868CAS No.: 2268794-52-9HPK1-IN-27 is a potent inhibitor of HPK1. MAP4K1 is also known as hematopoietic progenitor kinase 1 (HPK1). MAP4K1 is a serine/threonine kinase and member of the germinal center kinase family. HPK1-IN-27 has the potential for the research of cancer diseases (extracted from patent WO2019016071A1, compound 38).
-
HPK1-IN-40-d2
0 ImagesCat. No.: HY-149773SCAS No.: 3032624-35-1HPK1-IN-40 (compound 49) is a potent and selective HPK1 inhibitor with an IC50 of 0.9 nM. HPK1-IN-40 reinvigorates T-cell receptor (TCR) signaling, promoting T-cell function and cytokine production in T cells while having anti-cancer activity.
-
HPK1-IN-28
0 ImagesCat. No.: HY-143869CAS No.: 2699603-89-7HPK1-IN-28 is a potent inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPK1) is a negative regulator of the activation response of dendritic cells (DCs), T cells and B cells. HPK1-IN-28 enhances the body's anti-tumor immunity. HPK1-IN-28 has the potential for the research of immune-related diseases, especially tumor (extracted from patent WO2021175270A1, compound 1).
